Psychopharmacological advances in eating disorders
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder (BED) are the primary eating disorders (EDs). The only psychopharmacological treatment options for EDs with approval in some countries include fluoxetine for BN and lisdexamfetamine for BED. Given the high comorbidity and genetic correlations with other psychiatric disorders, it seems possible that novel medications for these conditions might also be effective in EDs. Areas covered: The current scientific literature has increased our understanding of how medication could be beneficial for patients with EDs on a molecular, functional and behavioral level. On the basis of theoretical considerations about neurotransmitters, hormones and neural circuits, possible drug targets for the treatment of EDs may include signal molecules and receptors of the self-regulatory system such as serotonin, norepinephrine and glutamate, the hedonic system including opioids, cannabinoids and dopamine and the hypothalamic homeostatic system including histamine, ghrelin, leptin, insulin, and glucagon-like peptide-1. Expert commentary: The latest research points to an involvement of both the immune and the metabolic systems in the pathophysiology of EDs and highlights the importance of the microbiome. Therefore, the next few years may unveil drug targets for EDs not just inside and outside of the brain, but possibly even outside of the human body.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Psychopharmacological interventions are also effective evidence-based treatments for non-comorbid EDs, PTSD and related comorbid disorders, e.g., mood and anxiety disorders, but they should always be adjunctive to psychotherapeutic interventions for patients with ED + PTSD and related comorbidities (174–179) (see #9 in Figure 1).”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · cited 2×
“hormone insulin, and the fatty tissue hormone leptin [74].”
BackgroundAn atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255 · cited 8×
“If the main outcome criteria of an RCT were to include PROMs and PREMs regarding, for example, anxiety in addition to BMI changes, the RCT would be of benefit from a patients’ perspective and may improve the willingness to participate in the RCT [120].”
BackgroundInfluentialA preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940 · cited 1×
“and food intake is ghrelin which is produced in the stomach [75].”
BackgroundA Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382 · cited 1×
“It has been reported to lead to weight gain in patients with schizophrenia [113] on the”
BackgroundThe assessment of binge eating severity among obese persons
Gormally, J., Black, S., Daston, S., & Rardin, D. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90024-7 · Cited by 2,129 · cited 2×
“Drugs used for obesity may also reduce weight in BED as there is a significant overlap between both diagnoses [88-94].”
BackgroundBulimia nervosa: an ominous variant of anorexia nervosa
Russell, G. (1979) · Psychological Medicine · doi:10.1017/s0033291700031974 · Cited by 1,789
The outcome of anorexia nervosa in the 20th century
Steinhausen, H.-C. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1284 · Cited by 1,761 · cited 1×
“The most common causes of death in patients with AN are sudden cardiac death associated with ventricular arrhythmias and suicide [97-99].”
BackgroundPharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,511
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., Andreasen, A. H., Jensen, C. B., DeFronzo, R. A., & for the NN8022-1922 Study Group (2015) · JAMA · doi:10.1001/jama.2015.9676 · Cited by 1,198
Saper, C. B., Chou, T. C., & Elmquist, J. K. (2002) · Neuron · doi:10.1016/s0896-6273(02)00969-8 · Cited by 1,120
Gadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60205-5 · Cited by 1,064
Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., Kim, D. D., & Dunayevich, E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60888-4 · Cited by 1,036
The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders
Berridge, K. C., Ho, C.-Y., Richard, J. M., & DiFeliceantonio, A. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.003 · Cited by 873 · cited 4×
“Appetite control includes a complex integration of several neural circuits including those related to (1) self- and social regulation, learning and memory, (2) hedonic aspects associated with the desire to eat and pleasure during food consumption and satiation, and (3) the homeostatic regulation which integrates perip…”
BackgroundInfluentialKeski-Rahkonen, A., & Mustelin, L. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000278 · Cited by 820
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
on behalf of the NN8022-1807 Investigators, Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., Niskanen, L., Rasmussen, M. F., Rissanen, A., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.158 · Cited by 757
Neurobiology of food intake in health and disease
Morton, G. J., Meek, T. H., & Schwartz, M. W. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3745 · Cited by 748 · cited 4×
“Appetite control includes a complex integration of several neural circuits including those related to (1) self- and social regulation, learning and memory, (2) hedonic aspects associated with the desire to eat and pleasure during food consumption and satiation, and (3) the homeostatic regulation which integrates perip…”
BackgroundInfluentialGarvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., Schwiers, M., Day, W. W., & Bowden, C. H. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.024927 · Cited by 716
Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity · doi:10.1038/oby.2011.330 · Cited by 711
The Natural Course of Bulimia Nervosa and Binge Eating Disorder in Young Women
Fairburn, C. G. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.7.659 · Cited by 668
THE TREATMENT OF DEPRESSIVE STATES WITH G 22355 (IMIPRAMINE HYDROCHLORIDE)
KUHN, R. (1958) · American Journal of Psychiatry · doi:10.1176/ajp.115.5.459 · Cited by 615
Lilenfeld, L. R., Kaye, W. H., Greeno, C. G., Merikangas, K. R., Plotnicov, K., Pollice, C., Rao, R., Strober, M., Bulik, C. M., & Nagy, L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.603 · Cited by 599
Prevalence, Heritability, and Prospective Risk Factors for Anorexia Nervosa
Bulik, C. M., Sullivan, P. F., Tozzi, F., Furberg, H., Lichtenstein, P., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.305 · Cited by 598
Strober, M., Freeman, R., Lampert, C., Diamond, J., & Kaye, W. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.393 · Cited by 560
Wadden, T. A., Foreyt, J. P., Foster, G. D., Hill, J. O., Klein, S., O'Neil, P. M., Perri, M. G., Pi‐Sunyer, F. X., Rock, C. L., Erickson, J. S., et al. (2011) · Obesity · doi:10.1038/oby.2010.147 · Cited by 558
Duncan, L., Yilmaz, Z., Gaspar, H., Walters, R., Goldstein, J., Anttila, V., Bulik-Sullivan, B., Ripke, S., Eating Disorders Working Group of the Psychiatric Genomics Consortium, Thornton, L., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16121402 · Cited by 544
Recovery from anorexia nervosa and bulimia nervosa at 22-year follow-up
Eddy, K. T., Tabri, N., Thomas, J. J., Murray, H. B., Keshaviah, A., Hastings, E., Edkins, K., Krishna, M., Herzog, D. B., Keel, P. K., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10393 · Cited by 535
Binge eating disorder and obesity
de Zwaan, M. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801699 · Cited by 522
Kim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
(1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820020059008 · Cited by 371 · cited 1×
“It was tested in patients with BN yielding positive results [17] and approved by the US FDA in 1987.”
BackgroundUlfvebrand, S., Birgegård, A., Norring, C., Högdahl, L., & von Hausswolff-Juhlin, Y. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.09.008 · Cited by 352 · cited 1×
“Many patients are unaware that it is a recognized form of EDs and present for treatment for weightrelated issues or comorbid medical and psychiatric conditions such as affective and anxiety disorders [33,38].”
BackgroundMcElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2162 · Cited by 322
Opioid peptides and the control of human ingestive behaviour
Yeomans, M. R., & Gray, R. W. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00041-6 · Cited by 317
A genome-wide association study of anorexia nervosa
Boraska, V, Franklin, C. S., Floyd, J. A. B., Thornton, L. M., Huckins, L. M., Southam, L., Rayner, N. W., Tachmazidou, I., Klump, K. L., Treasure, J., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.187 · Cited by 317
Self-citationSymptom fluctuation in eating disorders: correlates of diagnostic crossover
Tozzi, F., Thornton, L. M., Klump, K. L., Fichter, M. M., Halmi, K. A., Kaplan, A. S., Strober, M., Woodside, D. B., Crow, S., Mitchell, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.732 · Cited by 317 · cited 1×
“This view is supported by the fact that there are many overlapping risk factors and symptoms [94, 100-104].”
BackgroundDavis, C. A., Levitan, R. D., Reid, C., Carter, J. C., Kaplan, A. S., Patte, K. A., King, N., Curtis, C., & Kennedy, J. L. (2009) · Obesity · doi:10.1038/oby.2009.52 · Cited by 314
Anorexia nervosa and obesity are associated with opposite brain reward response
Frank, G. K. W., Reynolds, J. R., Shott, M. E., Jappe, L., Yang, T. T., Tregellas, J. R., & O'Reilly, R. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.51 · Cited by 311
Executive functions and the self-regulation of eating behavior: A review
Dohle, S., Diel, K., & Hofmann, W. (2018) · Appetite · doi:10.1016/j.appet.2017.05.041 · Cited by 305
Risk factors across the eating disorders
Hilbert, A., Pike, K. M., Goldschmidt, A. B., Wilfley, D. E., Fairburn, C. G., Dohm, F.-A., Walsh, B. T., & Striegel Weissman, R. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.054 · Cited by 302
Eating disorders: the big issue
Schmidt, U., Adan, R., Böhm, I., Campbell, I. C., Dingemans, A., Ehrlich, S., Elzakkers, I., Favaro, A., Giel, K., Harrison, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00081-x · Cited by 291
Self-citationAronne, L. J., Wadden, T. A., Peterson, C., Winslow, D., Odeh, S., & Gadde, K. M. (2013) · Obesity · doi:10.1002/oby.20584 · Cited by 274
Cardiovascular complications of anorexia nervosa: A systematic review
Sachs, K. V., Harnke, B., Mehler, P. S., & Krantz, M. J. (2016) · International Journal of Eating Disorders · doi:10.1002/eat.22481 · Cited by 272
Issues for DSM-V: Should obesity be included as a brain disorder?
Volkow, N. D., & O’Brien, C. P. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.708 · Cited by 271
Bissada, H., Tasca, G. A., Barber, A. M., & Bradwejn, J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07121900 · Cited by 268
Hormonal and neural mechanisms of food reward, eating behaviour and obesity
Murray, S., Tulloch, A., Gold, M. S., & Avena, N. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.91 · Cited by 266
Avena, N. M., & Bocarsly, M. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.010 · Cited by 261
McElroy, S. L., Hudson, J., Ferreira-Cornwell, M. C., Radewonuk, J., Whitaker, T., & Gasior, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.275 · Cited by 254
Microbiome, inflammation, epigenetic alterations, and mental diseases
Alam, R., Abdolmaleky, H. M., & Zhou, J. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32567 · Cited by 240 · cited 1×
“alter this microbiome as well as immune and brain function [179] and could therefore have therapeutic potential to influence appetite regulation and ED psychopathology [180].”
BackgroundSolmi, M., Veronese, N., Favaro, A., Santonastaso, P., Manzato, E., Sergi, G., & Correll, C. U. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.031 · Cited by 222
Long-Term Fluoxetine Treatment of Bulimia Nervosa
Goldstein, D. J., Wilson, M. G., Thompson, V. L., Potvin, J. H., Rampey, A. H., & The Fluoxetine Bulimia Nervosa Research Group (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.5.660 · Cited by 215
Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats
Morton, G. J., Thatcher, B. S., Reidelberger, R. D., Ogimoto, K., Wolden-Hanson, T., Baskin, D. G., Schwartz, M. W., & Blevins, J. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00296.2011 · Cited by 213 · cited 2×
“development of EDs is the neuropeptide hormone oxytocin which has been shown to inhibit food intake and to increase energy expenditure in animals [116,117].”
BackgroundA genome-wide association study on common SNPs and rare CNVs in anorexia nervosa
Wang, K., Zhang, H., Bloss, C. S., Duvvuri, V, Kaye, W., Schork, N. J., Berrettini, W., Hakonarson, H., & the Price Foundation Collaborative Group (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.107 · Cited by 212 · cited 2×
“On top of these pioneering diagnostic and therapeutic advances, there was significant progress in other research areas such as epidemiology and comorbidity research [32-40], genetics [41-51], research on neural circuits and neurotransmitters [52-83] and on hormonal appetite regulation [84-87].”
BackgroundHoopes, S. P., Reimherr, F. W., Hedges, D. W., Rosenthal, N. R., Kamin, M., Karim, R., Capece, J. A., & Karvois, D. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1109 · Cited by 211
Patterns of nonrandom mating within and across 11 major psychiatric disorders
Nordsletten, A. E., Larsson, H., Crowley, J. J., Almqvist, C., Lichtenstein, P., & Mataix-Cols, D. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3192 · Cited by 210 · cited 8×
“If the main outcome criteria of an RCT were to include PROMs and PREMs regarding, for example, anxiety in addition to BMI changes, the RCT would be of benefit from a patients’ perspective and may improve the willingness to participate in the RCT [120].”
BackgroundInfluentialRomano, S. J., Halmi, K. A., Sarkar, N. P., Koke, S. C., & Lee, J. S. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.96 · Cited by 210
Aigner, M., Treasure, J., Kaye, W., Kasper, S., & The WFSBP Task Force on Eating Disorders (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.602720 · Cited by 207 · cited 5×
“have already summarized the results of RCTs in BN for antidepressants, antiepileptics, lithium, and other drugs [12,23],”
BackgroundResultInfluentialSelf-citationDrewnowski, A., Krahn, D., Demitrack, M., Nairn, K., & Gosnell, B. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1206 · Cited by 197 · cited 3×
“A number of different neural messenger molecules such as endogenous opiates and cannabinoids and dopamine are involved in the in the reward system [68-72].”
BackgroundDeficient Activity in the Neural Systems That Mediate Self-regulatory Control in Bulimia Nervosa
Marsh, R., Steinglass, J. E., Gerber, A. J., Graziano O’Leary, K., Wang, Z., Murphy, D., Walsh, B. T., & Peterson, B. S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.504 · Cited by 190 · cited 1×
“which are important for the regulatory control of food intake [51,104].”
BackgroundTreatment of anorexia nervosa: Insights and obstacles
Guarda, A. S. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.020 · Cited by 189 · cited 1×
“vast majority of AN patients [173], only about 30% of patients with AN have recovered after 9 years [1] and patients with BED remain obese.”
BackgroundBlevins, J. E., Graham, J. L., Morton, G. J., Bales, K. L., Schwartz, M. W., Baskin, D. G., & Havel, P. J. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00441.2014 · Cited by 187
Nazar, B. P., Bernardes, C., Peachey, G., Sergeant, J., Mattos, P., & Treasure, J. (2016) · International Journal of Eating Disorders · doi:10.1002/eat.22643 · Cited by 182
Self-citationChronic Dieting and Eating Disorders: A Spiral Model
Heatherton, T. F., & Polivy, J. (2013) · doi:10.4324/9780203782286-15 · Cited by 181
Hedonic and incentive signals for body weight control
Egecioglu, E., Skibicka, K. P., Hansson, C., Alvarez-Crespo, M., Friberg, P. A., Jerlhag, E., Engel, J. A., & Dickson, S. L. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9166-4 · Cited by 173
Reward processing in anorexia nervosa
Keating, C., Tilbrook, A. J., Rossell, S. L., Enticott, P. G., & Fitzgerald, P. B. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.01.036 · Cited by 172
Faris, P. L., Kim, S. W., Meller, W. H., Goodale, R. L., Oakman, S. A., Hofbauer, R. D., Marshall, A. M., Daughters, R. S., Banerjee-Stevens, D., Eckert, E. D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)09062-5 · Cited by 168
Kaye, W. H., Wierenga, C. E., Bailer, U. F., Simmons, A. N., Wagner, A., & Bischoff-Grethe, A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.002 · Cited by 166
Intranasal Insulin Suppresses Food Intake via Enhancement of Brain Energy Levels in Humans
Jauch-Chara, K., Friedrich, A., Rezmer, M., Melchert, U. H., G. Scholand-Engler, H., Hallschmid, M., & Oltmanns, K. M. (2012) · Diabetes · doi:10.2337/db12-0025 · Cited by 164
Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults
Gantz, I., Erondu, N., Mallick, M., Musser, B., Krishna, R., Tanaka, W. K., Snyder, K., Stevens, C., Stroh, M. A., Zhu, H., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1806 · Cited by 163 · cited 2×
“the CB1 receptor antagonist taranabant [161], the peptide YY3-36 [162] which is a product of enteroendocrine cells, the pancreatic and lipase inhibitor cetilistat [163].”
BackgroundAntidepressants versus placebo for people with bulimia nervosa
Bacaltchuk, J., & Hay, P. P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003391 · Cited by 163
Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial
Andries, A., Frystyk, J., Flyvbjerg, A., & Støving, R. K. (2014) · International Journal of Eating Disorders · doi:10.1002/eat.22173 · Cited by 158
Amitriptyline in the Treatment of Anorexia Nervosa: A Double-Blind, Placebo-Controlled Study
Biederman, J., Herzog, D. B., Rivinus, T. M., Harper, G. P., Ferber, R. A., Rosenbaum, J. F., Harmatz, J. S., Tondorf, R., Orsulak, P. J., & Schildkraut, J. J. (1985) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198502000-00003 · Cited by 156
Olanzapine therapy in anorexia nervosa: psychobiological effects
Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., Ramaciotti, C., Bondi, E., Mellado, C., Borriello, R., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328080ca31 · Cited by 156 · cited 3×
“These preliminary proof-of-concept studies suggest that olanzapine [26,27,110,111], aripiprazole [125–127], or dronabinol”
BackgroundResultJukarainen, S., Heinonen, S., Rämö, J. T., Rinnankoski-Tuikka, R., Rappou, E., Tummers, M., Muniandy, M., Hakkarainen, A., Lundbom, J., Lundbom, N., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3095 · Cited by 151
Oxytocin as a possible mediator of SSRI-induced antidepressant effects
Uvnäs-Moberg, K., Björkstrand, E., Hillegaart, V., & Ahlenius, S. (1999) · Psychopharmacology · doi:10.1007/s002130050867 · Cited by 149
Vandereycken, W. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.144.3.288 · Cited by 147
A Placebo-Controlled Pilot Study of Adjunctive Olanzapine for Adolescents with Anorexia Nervosa
Kafantaris, V., Leigh, E., Hertz, S., Berest, A., Schebendach, J., Sterling, W. M., Saito, E., Sunday, S., Higdon, C., Golden, N. H., et al. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0139 · Cited by 145
Eating disorders and the serotonin connection: state, trait and developmental effects
Steiger, H. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0403 · Cited by 143
An FMRI study of self-regulatory control and conflict resolution in adolescents with bulimia nervosa
Marsh, R., Horga, G., Wang, Z., Wang, P., Klahr, K. W., Berner, L. A., Walsh, B. T., & Peterson, B. S. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010094 · Cited by 142 · cited 2×
“which are important for the regulatory control of food intake [51,104].”
BackgroundHenderson, G., Johnson, J. W., & Ascher, P. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018288 · Cited by 141
FRIEDERICH, H.-C., KUMARI, V., UHER, R., RIGA, M., SCHMIDT, U., CAMPBELL, I. C., HERZOG, W., & TREASURE, J. (2006) · Psychological Medicine · doi:10.1017/s0033291706008129 · Cited by 138
Self-citationZerwas, S., Larsen, J. T., Petersen, L., Thornton, L. M., Mortensen, P. B., & Bulik, C. M. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.003 · Cited by 127
Brain Regulation of Energy Metabolism
Roh, E., & Kim, M. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.4.519 · Cited by 125
The validity of the DSM-IV scheme for classifying bulimic eating disorders
Hay, P., & Fairburn, C. G. (1998) · International Journal of Eating Disorders · doi:10.1002/(sici)1098-108x(199801)23:1<1::aid-eat1>3.0.co;2-q · Cited by 124
Weight gain and metabolic changes during treatment with antipsychotics and antidepressants
Himmerich, H., Minkwitz, J., & Kirkby, K. (2015) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/1871530315666150623092031 · Cited by 122 · cited 1×
“αMSH is produced by the so-called pro-opiomelanocortin (POMC) neurons [78].”
BackgroundSelf-citationOlanzapine versus placebo for out-patients with anorexia nervosa
Attia, E., Kaplan, A. S., Walsh, B. T., Gershkovich, M., Yilmaz, Z., Musante, D., & Wang, Y. (2011) · Psychological Medicine · doi:10.1017/s0033291711000390 · Cited by 122
Heightened sensitivity to reward and punishment in anorexia nervosa
Jappe, L. M., Frank, G. K. W., Shott, M. E., Rollin, M. D. H., Pryor, T., Hagman, J. O., Yang, T. T., & Davis, E. (2011) · International Journal of Eating Disorders · doi:10.1002/eat.20815 · Cited by 119
Jensterle, M., Kravos, N. A., Pfeifer, M., Kocjan, T., & Janez, A. (2015) · Hormones · doi:10.1007/bf03401383 · Cited by 117
Javaras, K. N., Runfola, C. D., Thornton, L. M., Agerbo, E., Birgegård, A., Norring, C., Yao, S., Råstam, M., Larsson, H., Lichtenstein, P., et al. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22467 · Cited by 111
A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior
Burger, K. S., & Berner, L. A. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.04.025 · Cited by 110
Hedges, D. W., Reimherr, F. W., Hoopes, S. P., Rosenthal, N. R., Kamin, M., Karim, R., & Capece, J. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1208 · Cited by 104
Glutamate Mediates the Function of Melanocortin Receptor 4 on Sim1 Neurons in Body Weight Regulation
Xu, Y., Wu, Z., Sun, H., Zhu, Y., Kim, E. R., Lowell, B. B., Arenkiel, B. R., Xu, Y., & Tong, Q. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.003 · Cited by 103
From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour
Nathan, P. J., & Bullmore, E. T. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900039x · Cited by 103
Anderberg, R. H., Richard, J. E., Eerola, K., López-Ferreras, L., Banke, E., Hansson, C., Nissbrandt, H., Berqquist, F., Gribble, F. M., Reimann, F., et al. (2017) · Diabetes · doi:10.2337/db16-0755 · Cited by 99
Hedonic hunger and binge eating among women with eating disorders
Witt, A. A., & Lowe, M. R. (2014) · International Journal of Eating Disorders · doi:10.1002/eat.22171 · Cited by 96
The James Lind Alliance: tackling research mismatches
Petit-Zeman, S., Firkins, L., & Scadding, J. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60712-x · Cited by 96
Novel Mechanisms of Action of Three Antiepileptic Drugs, Vigabatrin, Tiagabine, and Topiramate
Ängehagen, M., Ben‐Menachem, E., Rönnbäck, L., & Hansson, E. (2003) · Neurochemical Research · doi:10.1023/a:1022393604014 · Cited by 94
Kopelman, P., de Groot, H. G., Rissanen, A., Rossner, S., Toubro, S., Palmer, R., Hallam, R., Bryson, A., & Hickling, R. I. (2010) · Obesity · doi:10.1038/oby.2009.155 · Cited by 93
Bone health in anorexia nervosa
Misra, M., & Klibanski, A. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32834b4bdc · Cited by 93
The use of opiate antagonists in treating bulimia: A study of low-dose versus high-dose naltrexone
Jonas, J. M., & Gold, M. S. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90062-5 · Cited by 91
Dold, M., Aigner, M., Klabunde, M., Treasure, J., & Kasper, S. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000369978 · Cited by 86
Self-citationThe Perfect Storm - A Bio-Psycho-Social Risk Model for Developing and Maintaining Eating Disorders
Frank, G. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00044 · Cited by 85
Overview of the treatment of binge eating disorder
McElroy, S. L., Guerdjikova, A. I., Mori, N., Munoz, M. R., & Keck, P. E. (2015) · CNS Spectrums · doi:10.1017/s1092852915000759 · Cited by 82
Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players
Meunier, C. N. J., Chameau, P., & Fossier, P. M. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00002 · Cited by 82
Pharmacotherapy of eating disorders
Davis, H., & Attia, E. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000358 · Cited by 82
Dynamic Interplay Among Homeostatic, Hedonic, and Cognitive Feedback Circuits Regulating Body Weight
Hall, K. D., Hammond, R. A., & Rahmandad, H. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301931 · Cited by 80
Neurobiological features of binge eating disorder
Balodis, I. M., Grilo, C. M., & Potenza, M. N. (2015) · CNS Spectrums · doi:10.1017/s1092852915000814 · Cited by 79
Leptin reduces hyperactivity in an animal model for anorexia nervosa via the ventral tegmental area
Verhagen, L. A. W., Luijendijk, M. C. M., & Adan, R. A. H. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.006 · Cited by 77
Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype
Meister, B., Gömüç, B., Suarez, E., Ishii, Y., Dürr, K., & Gillberg, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05157.x · Cited by 75 · cited 2×
“On top of these pioneering diagnostic and therapeutic advances, there was significant progress in other research areas such as epidemiology and comorbidity research [32-40], genetics [41-51], research on neural circuits and neurotransmitters [52-83] and on hormonal appetite regulation [84-87].”
BackgroundIssues for DSM-V: Should Obesity Be Included as a Brain Disorder?
Volkow, N. D. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.5.708 · Cited by 75
Males with anorexia nervosa: A controlled study of eating disorders in first‐degree relatives
Strober, M., Freeman, R., Lampert, C., Diamond, J., & Kaye, W. (2001) · International Journal of Eating Disorders · doi:10.1002/eat.1017 · Cited by 72
Genetic variants associated with disordered eating
Wade, T. D., Gordon, S., Medland, S., Bulik, C. M., Heath, A. C., Montgomery, G. W., & Martin, N. G. (2013) · International Journal of Eating Disorders · doi:10.1002/eat.22133 · Cited by 72
Koch, S. V., Larsen, J. T., Mouridsen, S. E., Bentz, M., Petersen, L., Bulik, C., Mortensen, P. B., & Plessen, K. J. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.153221 · Cited by 72
Fluoxetine as a treatment for bulimia nervosa.
Freeman, C. P. L., & Hampson, M. (1987) · PubMed · Cited by 67
Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders
Niciu, M. J., & Arias, A. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0096-4 · Cited by 67
Safety and Efficacy of Lorcaserin: A Combined Analysis of the BLOOM and BLOSSOM Trials
Aronne, L., Shanahan, W., Fain, R., Glicklich, A., Soliman, W., Li, Y., & Smith, S. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.10.2817 · Cited by 64
Intensive Nutritional Counselling in Bulimia Nervosa: A Role for Supplementation with Fluoxetine?
Beumont, P. J. V., Russell, J. D., Touyz, S. W., Buckley, C., Lowinger, K., Talbot, P., & Johnson, G. F. S. (1997) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679709065073 · Cited by 64
Kipnes, M. S., Hollander, P. A., Fujioka, K., Gantz, I., Seck, T. L., Erondu, N., Shentu, Y., Lu, K., Suryawanshi, S., Chou, M. Z., et al. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01188.x · Cited by 62
Caricilli, A. M., Penteado, E., de Abreu, L. L., Quaresma, P. G. F., Santos, A. C., Guadagnini, D., Razolli, D., Mittestainer, F. C., Carvalheira, J. B., Velloso, L. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1272 · Cited by 62
Gasior, M., Hudson, J., Quintero, J., Ferreira-Cornwell, M. C., Radewonuk, J., & McElroy, S. L. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000702 · Cited by 60
Are obesity risk genes associated with binge eating in adolescence?
Micali, N., Field, A. E., Treasure, J. L., & Evans, D. M. (2015) · Obesity · doi:10.1002/oby.21147 · Cited by 60
Self-citationAripiprazole in anorexia nervosa and low‐weight bulimia nervosa: Case reports
Trunko, M. E., Schwartz, T. A., Duvvuri, V., & Kaye, W. H. (2011) · International Journal of Eating Disorders · doi:10.1002/eat.20807 · Cited by 59
Effects of liraglutide in hypothalamic arcuate nucleus of obese mice
Barreto‐Vianna, A. R. C., Aguila, M. B., & Mandarim‐de‐Lacerda, C. A. (2016) · Obesity · doi:10.1002/oby.21387 · Cited by 58
Grisset, N. I., & Fitzgibbon, M. (1996) · Addictive Behaviors · doi:10.1016/0306-4603(95)00039-9 · Cited by 57
Kluge, M., Schacht, A., Himmerich, H., Rummel‐Kluge, C., Wehmeier, P. M., Dalal, M. A., Hinze‐Selch, D., Kraus, T., Dittmann, R., Pollmächer, T., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.009 · Cited by 57
Self-citationNeuroleptic effects of chlorpromazine in therapeutics of neuropsychiatry.
Delay, J., & Deniker, P. (1955) · PubMed · Cited by 57
Levinson, C. A., Rodebaugh, T. L., Fewell, L., Kass, A. E., Riley, E. N., Stark, L., McCallum, K., & Lenze, E. J. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09299 · Cited by 56 · cited 6×
“In this respect, we would like to refer again to oxytocin [116–119] and D-cycloserine [132].”
BackgroundInfluentialOpioids as facilitators of feeding: Can any food be rewarding?
Olszewski, P. K., Alsiö, J., Schiöth, H. B., & Levine, A. S. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.033 · Cited by 55
Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS
Badowski, M. E., & Pérez, S. E. (2016) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s81420 · Cited by 55
TNF-α and Ghrelin: Opposite Effects on Immune System, Metabolism and Mental Health
Himmerich, H., & Sheldrick, A. (2010) · Protein & Peptide Letters · doi:10.2174/092986610790225941 · Cited by 54
Self-citationSjödin, A. M., Gasteyger, C., Nielsen, A.-L. H., Raben, A., Mikkelsen, J. D., Jensen, J. K., Meier, D., & Astrup, A. V. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.87 · Cited by 52
Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among adult eating disorder patients
Svedlund, N. E., Norring, C., Ginsberg, Y., & von Hausswolff-Juhlin, Y. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1093-1 · Cited by 51
The hormonal signature of energy deficit: Increasing the value of food reward
Lockie, S. H., & Andrews, Z. B. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.003 · Cited by 50 · cited 2×
“It has to be mentioned though that neurotransmitters and hormones which belong to the homeostatic system like insulin, leptin and ghrelin play important roles in food reward [73-76, 84, 85] which is an example how the three systems – the self-regulatory, the hedonic and the homeostatic system – influence each other an…”
BackgroundAtypical Antipsychotics as Augmentation Therapy in Anorexia Nervosa
Marzola, E., Nadia, D., Giovannone, C., Amianto, F., Fassino, S., & Daga, G. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125569 · Cited by 48
Nathan, P. J., O'Neill, B. V., Bush, M. A., Koch, A., Tao, W. X., Maltby, K., Napolitano, A., Brooke, A. C., Skeggs, A. L., Herman, C. S., et al. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011399577 · Cited by 47
Moffett, P. M., Cartwright, L., Grossart, E. A., O'Keefe, D., & Kang, C. (2015) · Academic Emergency Medicine · doi:10.1111/acem.12836 · Cited by 47
Brockmeyer, T., Pellegrino, J., Münch, H., Herzog, W., Dziobek, I., & Friederich, H. (2016) · International Journal of Eating Disorders · doi:10.1002/eat.22574 · Cited by 47
Treatment of Antidepressant-Resistant Bulimia with Naltrexone
Jonas, J. M., & Gold, M. S. (1987) · The International Journal of Psychiatry in Medicine · doi:10.2190/0cmp-4xxh-3641-nrdw · Cited by 46
Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care
Kornstein, S. G. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.sh16003su1c.01 · Cited by 46
Anxious?depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?
Tollefson, G. D. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00164-9 · Cited by 45
Ard, J., Cannon, A., Lewis, C. E., Lofton, H., Vang Skjøth, T., Stevenin, B., & Pi‐Sunyer, X. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12632 · Cited by 43
Laboratory Parameters and Appetite Regulators in Patients with Anorexia Nervosa
Himmerich, H., Schönknecht, P., Heitmann, S., & Sheldrick, A. J. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000369969.87779.1c · Cited by 42
Self-citationCan attention to the intestinal microbiota improve understanding and treatment of anorexia nervosa?
Carr, J., Kleiman, S. C., Bulik, C. M., Bulik-Sullivan, E. C., & Carroll, I. M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1166953 · Cited by 39
Yellowlees, A. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.146.6.648 · Cited by 38
Glutamate Modulators in the Treatment of Obsessive-Compulsive Disorder
Pittenger, C. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150602-06 · Cited by 37
Aripiprazole, a partial dopamine agonist to improve adolescent anorexia nervosa—A case series
Frank, G. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22485 · Cited by 36
Kyriakidis, M., Caetano, L. B., Anastasiadou, N., Karasu, T., & Lashen, H. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.01.018 · Cited by 36
Psychopharmacological Treatment of Anorexia Nervosa and Bulimia: Review and Synthesis
JOHNSON, G., Stuckey, M., & Mitchell, J. G. (1983) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198309000-00002 · Cited by 35
Psychopharmacological options for adult patients with anorexia nervosa
Miniati, M., Mauri, M., Ciberti, A., Mariani, M. G., Marazziti, D., & Dell’Osso, L. (2016) · CNS Spectrums · doi:10.1017/s1092852914000790 · Cited by 34
Pisetsky, D. S., Trace, S. E., Brownley, K. A., Hamer, R. M., Zucker, N. L., Roux-Lombard, P., Dayer, J.-M., & Bulik, C. M. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.018 · Cited by 34
Nutritional Controls of Food Reward
Fernandes, M. F., Sharma, S., Hryhorczuk, C., Auguste, S., & Fulton, S. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.04.004 · Cited by 33
Alvarenga, M. D. S., Koritar, P., Pisciolaro, F., Mancini, M. C., Córdas, T. A., & Scagliusi, F. B. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.04.032 · Cited by 32
An open trial of reboxetine in obese patients with binge eating disorder
Silveira, R. O., Zanatto, V. C., Appolinário, J. C., & Kapczinski, F. P. (2005) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03327498 · Cited by 29
Volkoff, H. (2012) · Fish Physiology and Biochemistry · doi:10.1007/s10695-012-9756-4 · Cited by 28
Mood spectrum comorbidity in patients with anorexia and bulimia nervosa
Miniati, M., Benvenuti, A., Bologna, E., Maglio, A., Cotugno, B., Massimetti, G., Calugi, S., Mauri, M., & Dell’Osso, L. (2016) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-016-0333-1 · Cited by 28
Harrold, J. A., & Halford, J. C. G. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906778773616 · Cited by 27
Role of neuropeptide Y and proopiomelanocortin in fluoxetine-induced anorexia
Myung, C., Kim, B.-T., Choi, S. H., Song, G., Lee, S., & Jahng, J. W. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02969363 · Cited by 26
Kanerva, R., Rissanen, A., & Sarna, S. J. (1995) · Nordic Journal of Psychiatry · doi:10.3109/08039489509011912 · Cited by 26
Himmerich, H., Joaquim, M., Bentley, J., Kan, C., Dornik, J., Treasure, J. L., & Schmidt, U. H. (2017) · CNS Spectrums · doi:10.1017/s1092852917000529 · Cited by 25
Self-citationSuccessful treatment of anorexia nervosa with imipramine.
Jh, W., & Nl, S. (1977) · PubMed · Cited by 24
Discussing the Putative Role of Obesity-Associated Genes in the Etiopathogenesis of Eating Disorders
Gervasini, G., & Gamero‐Villarroel, C. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.77 · Cited by 23
Binge eating disorder in obesity: Comparison of different therapeutic strategies
Molinari, E., Baruffi, M., Croci, M., Marchi, S., & Petroni, M. L. (2005) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03327542 · Cited by 22
Torsello, A., Brambilla, F., Tamiazzo, L., Bulgarelli, I., Rapetti, D., Bresciani, E., & Locatelli, V. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03349245 · Cited by 19
Pharmakotherapie von Anorexia nervosa und Bulimia nervosa: State of the Art
Greetfeld, M., Cuntz, U., & Voderholzer, U. (2011) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0031-1281845 · Cited by 17
Sex Steroids Regulation of Appetitive Behavior
Bautista, C. J., Martínez‐Samayoa, P. M., & Zambrano, E. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712802762176 · Cited by 16
Olanzapine Treatment for Patients with Anorexia Nervosa
Himmerich, H., Au, K., Dornik, J., Bentley, J., Schmidt, U. H., & Treasure, J. L. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717709967 · Cited by 15
Self-citationAragona, M. (2007) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03327643 · Cited by 14
Roland Kuhn—100th Birthday of an Innovator of Clinical Psychopharmacology
Steinberg, H., & Himmerich, H. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4061 · Cited by 10
Self-citationDonepezil (aricept) as a treatment for anorexia nervosa: a very feasible therapeutic possibility
Bucay, A. H. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902810360 · Cited by 5
Laborwertveränderungen bei Anorexia nervosa
Baumann, Heitmann, Bubendorff, & Himmerich (2010) · Praxis · doi:10.1024/1661-8157/a000145 · Cited by 5
Medikamente zur Behandlung von Essstörungen und Adipositas
Himmerich, H., & Benkert, O. (2016) · Springer eBooks · doi:10.1007/978-3-662-50333-1_9 · Cited by 2
Self-citationBeating obesity: Help patients Control Binge Eating Disorder and Night Eating Syndrome
Cloak, N. L., & Powers, P. S. (2006) · Cited by 2
Research works printed but not linked: 16
- Delay J, 1955, J Clin Exp Psychopathol, 16, 104
- Thuillier J., 1980, Les dix ans qui ont changé la folie
- Steinberg H, 2012, Psychopharmacol Bull, 45, 48
- 10.1097/00005053-198309000-00002 · DOI
- White JH, 1977, Dis Nerv Syst, 38, 567
- American Psychiatric Association, 1980, Diagnostic diagnostic and statistical manual of mental disorders and statistical manual of mental disorders
- Freeman CPL, 1987, Int J Obes, 1, 163
- Bacaltchuk J, 2003, Cochrane Database Syst Rev, CD003391
- Bacaltchuk J, 2001, Cochrane Database Syst Rev, CD003385
- 10.1002/(sici)1098-108x(199801)23:1<57::aid-eat7>3.0.co;2-0 · doi:10.1002/(sici)1098-108x(199801)23:1<57::aid-eat7>3.0.co;2-0
- Treasure J, 2011, Understanding neuropsychiatric disorders: insights from neuroimaging, 510
- Steiger H, 2004, J Psychiatry Neurosci, 29, 20
- Cloak NL, 2006, Curr Psychiatr, 5, 17
- Heatherton TF, 1992, The etiology of bulimia: the individual and family context, 133
- 10.1002/(sici)1098-108x(199801)23:1<7::aid-eat2>3.0.co;2-q · DOI · Paper page
- Badowski ME, 2016, Hiv Aids, 8, 37
Cited by
Treasure, J., Willmott, D., Ambwani, S., Cardi, V., Clark Bryan, D., Rowlands, K., & Schmidt, U. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030630 · Cited by 211
Self-citationWeibel, S., Menard, O., Ionita, A., Boumendjel, M., Cabelguen, C., Kraemer, C., Micoulaud-Franchi, J.-A., Bioulac, S., Perroud, N., Sauvaget, A., et al. (2020) · L'Encéphale · doi:10.1016/j.encep.2019.06.005 · Cited by 151
A meta-analysis of cytokine concentrations in eating disorders
Dalton, B., Bartholdy, S., Robinson, L., Solmi, M., Ibrahim, M. A. A., Breen, G., Schmidt, U., & Himmerich, H. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.06.002 · Cited by 197
Self-citationSevere and enduring anorexia nervosa: Update and observations about the current clinical reality
Wonderlich, S. A., Bulik, C. M., Schmidt, U., Steiger, H., & Hoek, H. W. (2020) · International Journal of Eating Disorders · doi:10.1002/eat.23283 · Cited by 143
Himmerich, H., Lewis, Y. D., Conti, C. M., Mutwalli, H., Karwautz, A. F. K., Sjögren, J. M., Uribe-Isaza, M. M., Tyszkiewicz‐Nwafor, M., Aigner, M., McElroy, S. L., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2023.2179663 · Cited by 153
Self-citation
Metadata
- Authors
- Himmerich, H., & Treasure, J.
- Affiliations
- King's College London (GB)
- Corresponding author
- Himmerich, Hubertus
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2017-10-05
- Volume
- 11
- Issue
- 1
- Pages
- 95-108
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W2758282405
- Cited by
- 119
- References
- 174
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 15 · 2023: 16 · 2022: 17 · 2021: 7 · 2020: 16 · 2019: 17 · 2018: 13
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Licence
- other-oa
- Locations
- Expert Review of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- BiblioBoard Library Catalog (Open Research Library) (submittedVersion, cc-by-nc-nd)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- eating disorders, anorexia nervosa, bulimia nervosa, binge eating disorder, psychopharmacology, therapeutic target, serotonin, norepinephrine, glutamate, opioids, cannabinoids, dopamine, ghrelin, leptin, insulin, glucagon-like peptide-1, immune system, metabolic systems, gut microbiota, neurotransmitters, hormones, neural circuits
- MeSH terms
- Lisdexamfetamine Dimesylate, Animals, Anorexia Nervosa, Fluoxetine, Humans, Drug Design, Bulimia Nervosa, Binge-Eating Disorder, Molecular Targeted Therapy, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.